Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Consort Medical plc
Consort Medical plc
Activities:
Manufacturing
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Realtime flowmeters provide full software connectivity to HPLC data system
The RC.net/ICF compatible software allows users to gather accurate and precise flow readings while using chromatography software packages
Touchlight Genetics and the NPL awarded grant to develop single-stranded genome editing template
The grant will allow the development of mbDNA for genome editing, designed to replace the need for viral vectors
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Manufacturing
Recipharm and Consort Medical agree takeover to integrate CDMO services
The Board of Consort has confirmed its unanimous intention to recommend a cash offer of US$652m for the acquisition
Manufacturing
Consort Medical backs Mylan in FDA approval for generic version of Advair
British CDMO has built a 5,500 sqm dedicated cleanroom at its King’s Lynn site to support production of the dry powder inhaler
Manufacturing
Consort Medical upgrades European facilities
Global CDMO invests in manufacturing and packaging capabilities for Aesica production plants in Italy and Germany
Media
Consort Medical signs agreement with Opiant Pharmaceuticals
Subsidiaries Bespak and Aesica will jointly develop, with the specialty pharmaceutical company, a ready-to-use nasal delivered version of nalmefene to treat opioid overdoses
Recruitment
CFO appointment for Consort Medical
Consort Medical announces that Paul Hayes, Group Finance Director of The Vitec Group, is to succeed Richard Cotton as Consort Medical’s Group Chief Financial Officer (CFO)
Drug Delivery
Consort Medical closes Syrina auto-injector master development agreement
Consort Medical is pleased to announce that Bespak has entered into a master development agreement including key commercial supply terms with a leading global biopharmaceutical company
Drug Delivery
Bespak signs new scale-up and commercial supply agreement
Pressurised metered dose inhaler technology will be used in respiratory devices to treat COPD
Subscribe now